发明名称 |
PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS |
摘要 |
A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA):;;wherein R1, R2, R3, R4 and R5 are as defined herein. |
申请公布号 |
US2015291526(A1) |
申请公布日期 |
2015.10.15 |
申请号 |
US201314648217 |
申请日期 |
2013.12.12 |
申请人 |
KONDREDDI Ravinder Reddy;MANJUNATHA Ujjini H.;MA Ngai Ling;PEUKERT Stefan;RAO Srinivasa PS |
发明人 |
Kondreddi Ravinder Reddy;Ma Ngai Ling;Peukert Stefan;Rao Srinivasa P S;Ujjini Manjunatha |
分类号 |
C07D213/69;C07D405/06;A61K31/4433;A61K45/06;C07F9/58;A61K31/675;C07D401/04;A61K31/4439;A61K31/4412;A61K31/444 |
主分类号 |
C07D213/69 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of Formula (I)wherein
R1 is H, methyl or ethyl; R2 is phenyl, pyrrole or pyrazole, wherein said phenyl is optionally substituted with one or more substituents independently selected from fluoro or chloro; provided that when said substituent is chloro, said chloro is on the meta or ortho position of said phenyl and the number of chloro substituent is not more than one; R3 is a structural formula selected from the group consisting ofwhere R100 and R200 are each independently selected from the group consisting of H, (C1-C6)alkyl, cycloalkyl, an organic cation and an inorganic cation;
R4 is H or —C(═O)NH2; R5 is selected from the group consisting of (C1-C6)alkyl, cycloalkyl, phenyl, heterocycle and heteroaryl, optionally substituted with one or more independent R300 substituents; and R300 is selected from the group consisting of H, (C1-C6)alkyl, cycloalkyl, hydroxy, amino and F;or a pharmaceutically acceptable salt thereof. |
地址 |
US |